Beyond The Numbers: 7 Analysts Discuss Quest Diagnostics Stock

Published by
Benzinga

Analysts’ ratings for Quest Diagnostics (NYSE:DGX) over the last quarter vary from bullish to bearish, as provided by 7 analysts. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $146.57, along with a high estimate of $160.00 and a low estimate of $137.00. Observing a 4.91% increase, the current average has risen from the previous average price target of $139.71. Inves…

Read More

See also  U.S. court upholds hospital employee COVID-19 vaccine rule in test case

Leave a Reply